Logos Global Management LP Biogen Inc. Transaction History
Logos Global Management LP
- $775 Million
- Q2 2025
A detailed history of Logos Global Management LP transactions in Biogen Inc. stock. As of the latest transaction made, Logos Global Management LP holds 200,000 shares of BIIB stock, worth $30.1 Million. This represents 3.24% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$30.1 Million% of portfolio
3.24%Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,031Shares Held
131MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.6 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.38 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.19 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.12 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$722 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.7B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...